Alexandra Glucksmann Joins REGENXBIO Board of Directors

Alexandra Glucksmann Joins REGENXBIO Board of Directors

Dr. Glucksmann brings 25 years of R&D leadership and operations expertise to the role ROCKVILLE, Md., May 29, 2018 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based